By Associate Professor Min Jun

Book Chapters

Jun M; Perkovic V, 2015, 'Fibrates: risk-benefits and role in treating dyslipidemias', in Dyslipidemias Pathophysiology, Evaluation and Management, Humana Press

Jun M; Perkovic V; Cass A, 2011, 'Intensive glycemic control and renal outcome', in Diabetes and the Kidney, Karger Medical and Scientific Publishers

Journal articles

Lin J; Milder TY; Deakin CT; de Oliveira Costa J; Havard A; Neuen BL; Buckley NA; Brieger D; Greenfield JR; Jun M; Day RO; Pearson SA; Falster MO, 2025, 'Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based study', Diabetes Research and Clinical Practice, 224, pp. 112242, http://dx.doi.org/10.1016/j.diabres.2025.112242

Zhu Y; Jun M; Fletcher RA; Arnott C; Neuen BL; Kotwal SS, 2025, 'Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial', Diabetes, Obesity and Metabolism, 27, pp. 3531 - 3535, http://dx.doi.org/10.1111/dom.16363

Wallace H; Wick J; Ketema DB; Buizen L; Woodward M; Peiris D; Neuen BL; Robertson C; Nelson C; Chalmers J; Badve SV; Kotwal SS; Ronksley P; Gallagher M; Jun M, 2025, 'Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset', The Lancet Regional Health - Western Pacific, 57, http://dx.doi.org/10.1016/j.lanwpc.2025.101541

Siriwardana A; Buizen L; Jun M; Kotwal S; Arnott C; Jardine MJ; Levin A; Heerspink HJL; Charytan DM; Pollock C; Perkovic V; Neuen BL, 2025, 'Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial', Diabetes, Obesity and Metabolism, 27, pp. 1972 - 1979, http://dx.doi.org/10.1111/dom.16190

Chan B; Varghese A; Badve SV; Pecoits-Filho R; Guedes M; Arnott C; Kozor R; O'Lone E; Jun M; Kotwal S; Block GA; Chertow GM; Solomon SD; Vaduganathan M; Perkovic V; Neuen BL, 2025, 'Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD', Kidney International Reports, 10, pp. 1037 - 1049, http://dx.doi.org/10.1016/j.ekir.2025.01.029

Feng Y; Jun M; Wang AY; Ren S; Weisbord SD; Bellomo R; Ostermann M; Arnott C; Gallagher M, 2025, 'Predicting Contrast-Associated Acute Kidney Injury', JAMA Network Open, 8, http://dx.doi.org/10.1001/jamanetworkopen.2025.0107

Milder TY; Lin J; Pearson SA; de Oliveira Costa J; Neuen BL; Pollock C; Jun M; Greenfield JR; Day RO; Stocker SL; Brieger D; Falster MO, 2025, 'Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?', Diabetes, Obesity and Metabolism, 27, pp. 997 - 1000, http://dx.doi.org/10.1111/dom.16061

Kim D; Lee J; Toyama T; Liyanage T; Woodward M; Matsushita K; Hooi LS; Lin MY; Iseki K; Jha V; Wong MG; Jun M, 2025, 'Prevalence and Treatment Patterns of Anaemia in Individuals With Chronic Kidney Disease Across Asia: A Systematic Review and Meta-Analysis', Nephrology, 30, http://dx.doi.org/10.1111/nep.70002

See EJ; Cullen V; Krishnasamy R; Boag J; Coolican H; Craig J; Fortnum D; Guha C; Howell M; Johnston B; Jun M; Lambert K; Lee V; Nguyen T; Scuderi C; Tunnicliffe D; Viecelli A; Walker R; Chiekh Hassan HI; Light C, 2025, 'Commentary on the 2021 update of the KDIGO clinical practice guideline for management of blood pressure in chronic kidney disease', Nephrology, 30, http://dx.doi.org/10.1111/nep.14414

Lam D; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Levin A; McArthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M; Jun M; Ha JT, 2025, 'Safety and Effectiveness of Apixaban versus Warfarin by Kidney Function in Atrial Fibrillation', Kidney360, http://dx.doi.org/10.34067/KID.0000000809

Neuen BL; Ostrominski JW; Claggett B; Beldhuis IE; Chatur S; McCausland FR; Badve SV; Arnott C; Heerspink HJL; Jun M; Falster M; de Oliveira Costa J; Pollock C; Jardine MJ; Mahaffey KW; Perkovic V; Solomon SD; Vaduganathan M, 2024, 'Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes', Journal of the American College of Cardiology, 84, pp. 2246 - 2250, http://dx.doi.org/10.1016/j.jacc.2024.08.006

Cashmore B; Tunnicliffe DJ; Palmer S; Blythen L; Boag J; Kostner K; Krishnasamy R; Lambert K; Miller A; Mullan J; Patu M; Phoon RKS; Rix L; Trompf N; Johnson DW; Walker R; Lee V; Boag J; Coolican H; Cullen V; Fortnum D; Hassan H; Jun M; Craig J; Light C; Nguyen T; Scuderi C; See E; Viecelli A; Walker R, 2024, 'Australian and New Zealand Living Guideline cholesterol-lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence-practice gap', Nephrology, 29, pp. 495 - 509, http://dx.doi.org/10.1111/nep.14295

Maeda T; Woodward M; Jun M; Sakamoto Y; Chen X; Matsushita K; Mancia G; Arima H; Anderson CS; Chalmers J; Harris K, 2024, 'Risk of recurrent stroke and dementia following acute stroke by changes in kidney function: results from the Perindopril Protection Against Recurrent Stroke Study', Journal of Hypertension, 42, pp. 1313 - 1321, http://dx.doi.org/10.1097/HJH.0000000000003711

Scholes-Robertson N; Guha C; Gutman T; Howell M; Yip A; Cashmore B; Roberts I; Lopez-Vargas P; Wong G; MacGinley R; Synnot A; Craig JC; Jauré A; Krishnasamy R; Tunnicliffe DJ; Lee V; Boag J; Coolican H; Cullen V; Fortnum D; Hassan H; Jun M; Lambert K; Light C; Nguyen T; Palmer S; Scuderi C; See E; Viecelli A; Walker R, 2024, 'Consumer involvement in the development and dissemination of chronic kidney disease guidelines: a summary of a meaningful and sustainable approach developed by Caring for Australians and New ZealandeRs with kidney Impairment guidelines', Journal of Clinical Epidemiology, 170, http://dx.doi.org/10.1016/j.jclinepi.2024.111330

Ha JT; Freedman SB; Kelly DM; Neuen BL; Perkovic V; Jun M; Badve SV, 2024, 'Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis', American Journal of Kidney Diseases, 83, pp. 350 - 359.e1, http://dx.doi.org/10.1053/j.ajkd.2023.07.023

Neuen BL; Jun M; Wick J; Kotwal S; Badve SV; Jardine MJ; Gallagher M; Chalmers J; Nallaiah K; Perkovic V; Peiris D; Rodgers A; Woodward M; Ronksley PE, 2024, 'Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data', The Lancet Regional Health - Western Pacific, 43, http://dx.doi.org/10.1016/j.lanwpc.2023.100988

Jun M; Wick J; Neuen BL; Kotwal S; Badve SV; Woodward M; Chalmers J; Peiris D; Rodgers A; Nallaiah K; Jardine MJ; Perkovic V; Gallagher M; Ronksley PE, 2024, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Kidney International Reports, 9, pp. 312 - 322, http://dx.doi.org/10.1016/j.ekir.2023.11.022

Ketema DB; Wallace H; Neuen BL; Kotwal SS; Ronksley PE; Badve S; Perkovic V; Gallagher MP; Joshi R; Jun M, 2024, 'Assessing the Quality of Care for People with CKD: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.2024bzcfkb63

Siriwardana A; Jardine M; Perkovic V; Jun M; Kotwal SS; Arnott CG; Neuen BL, 2024, 'Cardiovascular, Kidney, and Safety Outcomes with Canagliflozin in Older Adults: A Pooled Secondary Analysis of the CANVAS Program and CREDENCE Trial', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.2024e59ygyz9

Ha JT; Hiremath S; Jun M; Green SC; Wheeler DC; Coyne DW; Perkovic V; Badve SV, 2024, 'Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease.', NEJM Evid, 3, pp. EVIDoa2300189, http://dx.doi.org/10.1056/EVIDoa2300189

Yeung EK; Ferguson TW; Tangri N; Vaduganathan M; Arnott CG; Jun M; Kotwal SS; Jardine M; Perkovic V; Heerspink HJL; Neuen BL, 2024, 'Risk-Based Implementation of SGLT2 Inhibitors: Insights from the CANVAS Program and CREDENCE Trial', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.2024k6fn2ax5

Wallace H; Wick J; Ketema DB; Neuen BL; Jardine M; Lin J; Nelson CL; Pearson S; Peiris D; Woodward M; Ronksley PE; Gallagher MP; Kotwal SS; Jun M, 2024, 'Use of SGLT2 Inhibitors and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in Australian Primary Care Patients with Type 2 Diabetes Mellitus (T2DM) Stratified by CKD Status', Journal of the American Society of Nephrology, 35, pp. 10.1681/asn.2024f7q40fk1, http://dx.doi.org/10.1681/asn.2024f7q40fk1

Ha J; Hiremath S; Jun M; Palmer S; Wheeler D; Coyne D; Perkovic V; Badve S, 2024, 'WCN24-2313 LONG-TERM SAFETY OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS', Kidney International Reports, 9, pp. S562 - S563, http://dx.doi.org/10.1016/j.ekir.2024.02.1183

Colombijn JMT; Hooft L; Jun M; Webster AC; Bots ML; Verhaar MC; Vernooij RWM, 2023, 'Antioxidants for adults with chronic kidney disease', Cochrane Database of Systematic Reviews, 2023, http://dx.doi.org/10.1002/14651858.CD008176.pub3

Young TK; Hockham C; Sukkar L; Kang A; Jun M; Foote C; Baker J; Rogers K; Zoungas S; Cass A; Sullivan D; Jardine MJ, 2023, 'Duration and effectiveness of glucose-lowering regimens in the real world management of diabetes: Data from the Australian EXTEND45 Linked Cohort Study', Endocrine and Metabolic Science, 12, http://dx.doi.org/10.1016/j.endmts.2023.100135

Jun M; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Ha J; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Levin A; Mcarthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M, 2023, 'Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study', European Heart Journal - Quality of Care and Clinical Outcomes, 9, pp. 621 - 631, http://dx.doi.org/10.1093/ehjqcco/qcac069

Pettigrew S; Santos JA; Li Y; Jun M; Anderson C; Jones A, 2023, 'Short report: Factors contributing to young people's susceptibility to e-cigarettes in four countries', Drug and Alcohol Dependence, 250, http://dx.doi.org/10.1016/j.drugalcdep.2023.109944

Fletcher RA; Arnott C; Rockenschaub P; Schutte AE; Carpenter L; Vaduganathan M; Agarwal R; Bakris G; Chang TI; Heerspink HJL; Jardine MJ; Mahaffey KW; Neal B; Pollock C; Jun M; Rodgers A; Perkovic V; Neuen BL, 2023, 'Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials', Journal of the American Heart Association, 12, pp. e028516, http://dx.doi.org/10.1161/JAHA.122.028516

Ha JT; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Lam D; Levin A; McArthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M; Jun M, 2023, 'Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada', Kidney Medicine, 5, http://dx.doi.org/10.1016/j.xkme.2023.100675

Harris K; Muntner P; Woodward M; Jun M; Oshima M; Gong J; Harrap S; Menard J; Chalmers J, 2023, 'Clinical outcomes by atherosclerotic cardiovascular disease risk score and blood pressure level in high risk individuals with type 2 diabetes', Journal of Human Hypertension, 37, pp. 181 - 188, http://dx.doi.org/10.1038/s41371-022-00661-5

Pettigrew S; Alvin Santos J; Miller M; Sudhir Raj T; Jun M; Morelli G; Jones A, 2023, 'E-cigarettes: A continuing public health challenge in India despite comprehensive bans', Preventive Medicine Reports, 31, http://dx.doi.org/10.1016/j.pmedr.2022.102108

Feng Y; Wang AY; Jun M; Pu L; Weisbord SD; Bellomo R; Hong D; Gallagher M, 2023, 'Characterization of Risk Prediction Models for Acute Kidney Injury A Systematic Review and Meta-analysis', JAMA Network Open, 6, http://dx.doi.org/10.1001/jamanetworkopen.2023.13359

Talbot B; Cass A; Walker R; Hooi L; Jardine M; Jun M; Rogers K; Sukkar L; Smyth B; Gallagher M, 2023, 'Comparing survival in patients with chronic kidney disease across three countries – Results from the study of heart and renal protection-extended review', Nephrology, 28, pp. 36 - 43, http://dx.doi.org/10.1111/nep.14127

Ha J; Hiremath S; Jun M; Palmer S; Wheeler DC; Coyne DW; Perkovic V; Badve S, 2023, 'Long-Term Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in CKD: A Systematic Review and Meta-Analysis of Randomized Trials', Journal of the American Society of Nephrology, 34, pp. 367 - 367, http://dx.doi.org/10.1681/asn.20233411s1367a

Jun M; Wick J; Neuen BL; Kotwal SS; Badve S; Chalmers JP; Jardine M; Perkovic V; Gallagher MP; Ronksley PE, 2023, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Journal of the American Society of Nephrology, 34, pp. 373 - 373, http://dx.doi.org/10.1681/asn.20233411s1373a

KIM D; Lee J; Toyama T; Liyanage T; Woodward M; Matsushita K; Hooi LS; Lin MY; Iseki K; Jha V; Wong MG; Jun M, 2023, 'WCN23-0200 PREVALENCE AND TREATMENT PATTERNS OF ANAEMIA IN INDIVIDUALS WITH CHRONIC KIDNEY DISEASE ACROSS ASIA', Kidney International Reports, 8, pp. S135 - S136, http://dx.doi.org/10.1016/j.ekir.2023.02.309

Pettigrew S; Miller M; Santos JA; Brown K; Morelli G; Sudhir T; Jun M; Jones A, 2022, 'Young people's support for various forms of e-cigarette regulation in Australia and the UK', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103858

Pettigrew S; Miller M; Kannan A; Raj TS; Jun M; Jones A, 2022, 'School staff perceptions of the nature and consequences of students’ use of e-cigarettes', Australian and New Zealand Journal of Public Health, 46, pp. 676 - 681, http://dx.doi.org/10.1111/1753-6405.13281

Lambert K; Bahceci S; Harrison H; Chan M; Scholes-Robertson N; Johnson DW; Yip A; Viecelli AK; Krishnasamy R; Boag J; Coolican H; Craig J; Jun M; Lee V; Nguyen T; Scuderi C; See E; Walker R; Fortnum D; Cullen V; Howell M; Guha C; Tunnicliffe D; Johnston B, 2022, 'Commentary on the 2020 update of the KDOQI clinical practice guideline for nutrition in chronic kidney disease', Nephrology, 27, pp. 537 - 540, http://dx.doi.org/10.1111/nep.14025

Hockham C; Bao L; Tiku A; Badve SV; Bello AK; Jardine MJ; Jha V; Toyama T; Woodward M; Jun M, 2022, 'Sex differences in chronic kidney disease prevalence in Asia: A systematic review and meta-analysis', Clinical Kidney Journal, 15, pp. 1144 - 1151, http://dx.doi.org/10.1093/ckj/sfac030

Kang A; Sukkar L; Hockham C; Jun M; Young T; Scaria A; Foote C; Neuen BL; Cass A; Pollock C; Comino E; Lung T; Pecoits-Filho R; Rogers K; Jardine MJ; Chow C; Gallagher M; Jan S; Knight J; Liu B; McNamara M; Peiris D; Ssullivan D; Wong G; Zoungas S; Wilson R, 2022, 'Risk factors for incident kidney disease in older adults: an Australian prospective population-based study', Internal Medicine Journal, 52, pp. 808 - 817, http://dx.doi.org/10.1111/imj.15074

Campain A; Hockham C; Sukkar L; Rogers K; Chow CK; Lung T; Jun M; Pollock C; Cass A; Sullivan D; Comino E; Peiris D; Jardine M, 2022, 'Prior Cardiovascular Treatments—A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction', Frontiers in Pharmacology, 13, http://dx.doi.org/10.3389/fphar.2022.834898

Daniels B; Schaffer A; Buckley NA; Bruno C; Jun M; Pearson SA; Zoega H, 2022, 'The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, 31, pp. 370 - 378, http://dx.doi.org/10.1002/pds.5395

Chidwick K; Myton R; Rodgers A; Jun M; Dartnell J; Balcomb A; Dore G, 2022, 'A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP-HEPC trial)', Journal of Viral Hepatitis, 29, pp. 135 - 146, http://dx.doi.org/10.1111/jvh.13629

Liyanage T; Toyama T; Hockham C; Ninomiya T; Perkovic V; Woodward M; Fukagawa M; Matsushita K; Praditpornsilpa K; Hooi LS; Iseki K; Lin MY; Stirnadel-Farrant HA; Jha V; Jun M, 2022, 'Prevalence of chronic kidney disease in Asia: A systematic review and analysis', BMJ Global Health, 7, pp. e007525, http://dx.doi.org/10.1136/bmjgh-2021-007525

Fletcher RA; Arnott C; Rockenschaub P; Schutte AE; Carpenter L; Vaduganathan M; Heerspink HJ; Neal B; Jun M; Rodgers A; Perkovic V; Neuen B, 2022, 'Abstract P201: Canagliflozin, Visit-to-visit Blood Pressure Variability, And Risk Of Cardiovascular, Kidney, And Mortality Outcomes: Pooled Individual Participant Data From The CANVAS And CREDENCE Trials', Hypertension, 79, http://dx.doi.org/10.1161/hyp.79.suppl_1.p201

Ha J; Freedman B; Kelly DM; Neuen BL; Perkovic V; Jun M; Badve S, 2022, 'Lower Glomerular Filtration Rate and Higher Albuminuria Are Associated With Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 33, pp. 297 - 298, http://dx.doi.org/10.1681/asn.20223311s1297c

Daar DA; Anzai LM; Vranis NM; Schulster ML; Frey JD; Jun M; Zhao LC; Levine JP, 2022, 'Robotic deep inferior epigastric perforator flap harvest in breast reconstruction', MICROSURGERY, 42, pp. 319 - 325, http://dx.doi.org/10.1002/micr.30856

Back to profile page